Overview
In 1% of men with infertility, obstructive azoospermia (OA) may occur in congenital absence of the vas (CAVD) or idiopathic obstructive azoospermia . Many studies have shown that the pathogenic genes of OA are CFTR and ADGRG2 genes, and the inheritance mode is autosomal recessive. Although the conventional assisted reproductive technology(PESA/TESA) can help these patients have children, male patients who carry mutations of the disease-causing genes (CFTR and ADGRG2) will also pass on their mutations to the next generation, which will increase the risk of male offspring infertility. Therefore, genetic detection of CFTR and ADGRG2 genes is very necessary for CAVD patients before assisted reproduction. Genetic diagnosis plays a key role in preventing the disease to the offspring.
Eligibility
Inclusion Criteria:
- No sperm was found after centrifugation for 15min for two or more semen tests, and the interval between two tests was at least 2 weeks.
- Blood FSH is normal;
- Hematostatin b is normal;
- Chromosome karyotype is normal or polymorphic;
- Y chromosome microdeletion did not show the deletion:(main locus);
- Biochemical fructose of seminal plasma : less than the normal value;
- PH of semen <7.2;
- Transscrotal or transrectal ultrasound: normal testicular size(as measured by B ultrasound), presence or dysplasia of vas deferens and epididymis;
Exclusion Criteria:
- B ultrasound of urinary system suggested abnormal development;
- Transscrotal or Transrectal ultrasound indicated absence of vas deferens or epididymis or seminal vesicle;
- Physical examination showed the following abnormalities: cryptorchidism, tenderness of testis and epididymis;
- The following medical history: genitourinary tract trauma or surgical history; orchitis; epididymitis; Seminal vesicle disease; mumps;
- Laboratory examination: red and white blood cell elevation of semen routine